GALNT2 is associated with lipid levels (Teslovich et al. 2010), insulin signaling (Marucci et al. 2013a), hyperglycemia (Marucci et al. 2013b), and the malignant behavior of hepatocellular carcinoma (Wu et al. 2011). Here, INS is linked to hepatocellular carcinoma.